Cargando…

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease

The presence of cirrhosis in nonalcoholic-fatty-liver-disease (NAFLD) is the most important predictor of liver-related mortality. Limited data exist concerning the diagnostic accuracy of gut-microbiome-derived signatures for detecting NAFLD-cirrhosis. Here we report 16S gut-microbiome compositions o...

Descripción completa

Detalles Bibliográficos
Autores principales: Caussy, Cyrielle, Tripathi, Anupriya, Humphrey, Greg, Bassirian, Shirin, Singh, Seema, Faulkner, Claire, Bettencourt, Ricki, Rizo, Emily, Richards, Lisa, Xu, Zhenjiang Z., Downes, Michael R., Evans, Ronald M., Brenner, David A., Sirlin, Claude B., Knight, Rob, Loomba, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440960/
https://www.ncbi.nlm.nih.gov/pubmed/30926798
http://dx.doi.org/10.1038/s41467-019-09455-9
Descripción
Sumario:The presence of cirrhosis in nonalcoholic-fatty-liver-disease (NAFLD) is the most important predictor of liver-related mortality. Limited data exist concerning the diagnostic accuracy of gut-microbiome-derived signatures for detecting NAFLD-cirrhosis. Here we report 16S gut-microbiome compositions of 203 uniquely well-characterized participants from a prospective twin and family cohort, including 98 probands encompassing the entire spectrum of NAFLD and 105 of their first-degree relatives, assessed by advanced magnetic-resonance-imaging. We show strong familial correlation of gut-microbiome profiles, driven by shared housing. We report a panel of 30 features, including 27 bacterial features with discriminatory ability to detect NAFLD-cirrhosis using a Random Forest classifier model. In a derivation cohort of probands, the model has a robust diagnostic accuracy (AUROC of 0.92) for detecting NAFLD-cirrhosis, confirmed in a validation cohort of relatives of proband with NAFLD-cirrhosis (AUROC of 0.87). This study provides evidence for a fecal-microbiome-derived signature to detect NAFLD-cirrhosis.